0001104659-19-034521.txt : 20190607
0001104659-19-034521.hdr.sgml : 20190607
20190607160123
ACCESSION NUMBER: 0001104659-19-034521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190605
FILED AS OF DATE: 20190607
DATE AS OF CHANGE: 20190607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOVEN ANDREW I
CENTRAL INDEX KEY: 0001258673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 19885646
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE, SUITE 1710
STREET 2: C/O ARALEZ PHARMACEUTICALS INC.
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
a4.xml
4
X0306
4
2019-06-05
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001258673
KOVEN ANDREW I
C/O KALA PHARMACEUTICALS, INC.
490 ARSENAL WAY, SUITE 120
WATERTOWN
MA
02472
1
0
0
0
Stock Option (right to buy)
5.35
2019-06-05
4
A
0
21000
0
A
2029-06-04
Common Stock
21000
21000
D
This option was granted on June 5, 2019 and vests with respect to 1/12th of the shares underlying the option at the end of each successive one-month period thereafter.
/s/ Mary Reumuth, Attorney-in-Fact
2019-06-07